2-230010736-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_174899.5(FBXO36):c.419C>T(p.Ser140Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,613,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S140P) has been classified as Uncertain significance.
Frequency
Consequence
NM_174899.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO36 | ENST00000283946.8 | c.419C>T | p.Ser140Leu | missense_variant | Exon 4 of 4 | 1 | NM_174899.5 | ENSP00000283946.3 | ||
FBXO36 | ENST00000373652.7 | c.326C>T | p.Ser109Leu | missense_variant | Exon 5 of 5 | 1 | ENSP00000362756.3 | |||
FBXO36 | ENST00000409992.1 | c.359C>T | p.Ser120Leu | missense_variant | Exon 4 of 4 | 5 | ENSP00000386673.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152190Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000160 AC: 4AN: 250668 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461276Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726890 show subpopulations
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74342 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.419C>T (p.S140L) alteration is located in exon 4 (coding exon 4) of the FBXO36 gene. This alteration results from a C to T substitution at nucleotide position 419, causing the serine (S) at amino acid position 140 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at